LucioIannone
VP of Venture Investments Health
"Biotechnology is a mix of science and magic."
Investments and science
10 years experience in Biotech and early stage venture capital company creation. Learning about new technologies and their applications in medicine
Business
Highly curious, dynamic thinker, problem solver and definitely Type A personality
Connoisseur
I am passionate about boxing and wine, usually not at the same time
Cool dad
With two kids, my hobbies now are Lego, building trains, jumping in puddles and pretty much anything they are up to that day
Lucio Iannone is VP of Venture Investments Health at Leaps by Bayer. He is responsible for leading the investment team in the USA and deal execution. He is also involved in the sourcing, screening, and mentoring of companies with game-changing science.
As an investor, Lucio also serves as board member for Affini-T, Vesigen, Khloris Biosciences, Immunitas Therapeutics, eGenesis and Paratus Biosciences. Before joining Leaps by Bayer, he had different roles in biotechnology companies. He has experience with molecular biology, cell and gene therapy technologies and their application in oncology, cardiovascular and other therapeutic fields.
Lucio obtained his Ph.D. in Medicine at the Imperial College of London.